ORIC-533
ORIC
['multiple myeloma']
yesterday at the ash annual meeting we presented encouraging preclinical data in multiple myeloma for our cd73 inhibitor, oric-533. learn more about the data presented in the full press release here: #ash2022 
Our name=our mission. Dedicated to improving patients’ lives using precision oncology to develop novel therapies aimed at key tumor dependencies. (Nasdaq: ORIC)